Where does Foundation Medicine, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Foundation Medicine, Inc. ranks #8,385 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Foundation Medicine, Inc. hold?

Foundation Medicine, Inc. holds 38 US utility patents granted between 2016 and 2025, spanning 13 technology areas.

What is Foundation Medicine, Inc.'s Innovation Score?

Foundation Medicine, Inc. has an Innovation Score of 52.9 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Foundation Medicine, Inc.'s patent grant rate increasing or decreasing?

Foundation Medicine, Inc.'s recent grant velocity is +130% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Foundation Medicine, Inc.'s patents?

Foundation Medicine, Inc.'s patents average 27.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Foundation Medicine, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Foundation Medicine, Inc.

Q: What technology areas does Foundation Medicine, Inc. focus on?

Foundation Medicine, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 29 patents, ranking #159 of 2,502 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 38 granted patents across 13 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Foundation ranks #8,385 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 13 technology areas.

#8,385
of 49,997 US assignees by volume: Top 9%
by Innovation Score (52.9/100): 27.0
avg claims per patent: +130%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8385 · US Corporation #8,385 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,385/49,997
PHOTO-FINISH Fiberlean
CPC-FOCUS C12Q · 13 areas
INNOV-PAR 52.9/100
CLAIMS-DENSE 27.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +130% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fiberlean Technologies Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Foundation’s 52.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (24%) Velocity 12.5 pts (24%) Breadth 12.7 pts (24%) Claim depth 15.0 pts (28%)

Qualcomm Incorporated · highest

85
El · near

53
Foundation Medicine · this assignee

53
Japan Agency FOR… · near

53
Netease (HANGZHOU)… · near

53
Outotec (FINLAND) OY · near

53
3D Lighting… · lowest

7

What this shows Foundation's Innovation Score is 52.9/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Foundation?

Each dot is one of Foundation’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Foundation’s own 27.0 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Foundation vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Foundation's grants concentrate

Foundation Medicine, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 76.3% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2020. By volume, Foundation sits between Fiberlean Technologies Limited and Gemmy Industries Corporation.

Foundation's three-year grant acceleration

Foundation Medicine, Inc. shows 15 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Fiberlean

38
Flexiv

38
Frazier Industrial

38
Fonar

38
Fuze

38
GE Renewable Wind…

38
GEM Products

38
Gemmy Industries

38
Foundation Medici… ◀

38

What this shows Foundation holds 38 patents at rank #8,386, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Foundation

By rank, the assignees closest to #8,386 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Foundation's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Foundation, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Foundation ranks #159 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Japan Agency FOR Marine-earth Science AND Technology 53 Netease (HANGZHOU) Network Co., Ltd. 53 Outotec (FINLAND) OY 53 El Electronics LLC 53

Foundation's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Foundation Medicine, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	7.9%
2017	2	5.3%
2018	5	13.2%
2020	1	2.6%
2021	7	18.4%
2022	6	15.8%
2023	5	13.2%
2024	4	10.5%
2025partial year	5	13.2%

Which technologies does Foundation Medicine, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 29

C07K - Peptides 24

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 23

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 12

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 8

G06F - Electric Digital Data Processing 5

Y02A - Technologies FOR Adaptation TO Climate Change 5

C12Y - Enzymes 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Foundation Medicine, Inc.'s patent record in context - here's where to go next.

Foundation Medicine, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 76.3% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #8,385 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Foundation Medicine, Inc. against Fiberlean Technologies Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.